Facebook
Twitter
LinkedIn
Forward
To analyze clinical vignettes of unusual neuropsychiatric disorders.
To share a diagnostic and treatment approach for neuropsychiatric disorders with variable success.
To discuss challenges associated with the clinical care in neuropsychiatry and propose some solutions.
Presenter(s):
Ahmed Obeidat, M.D., Ph.D.
Assistant Professor
Department of Neurology
Neuroimmunology and Multiple Sclerosis
Director, Neuroimmunology and MS Fellowship Program
The Medical College of Wisconsin
All persons in control of content have NO relevant financial relationships to disclosure except:
| Name: | Company: | Role: |
| Ahmed Obeidat | Biogen, Alexion, Novartis, Genentech, Bristol Meyer Squib | Speakers Bureau |
| Ahmed Obeidat | Alexion, Sanofi/Genzyme, EMD Serono, Genetech, Celgene, Novartis | Consulting, member of advisory board, steering committee |
In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.